Solis-Leal A, Karlinsey D, Sithole S, Lopez J, Carlson A, Planelles V
Viruses. 2024; 16(10).
PMID: 39459974
PMC: 11512211.
DOI: 10.3390/v16101642.
Asia L, Jansen Van Vuren E, Lindeque Z, Williams M
Virol J. 2024; 21(1):47.
PMID: 38395987
PMC: 10893664.
DOI: 10.1186/s12985-024-02313-1.
Fernandes J, Branton W, Cohen E, Koopman G, Kondova I, Gelman B
Brain. 2023; 147(2):717-734.
PMID: 37931057
PMC: 10834258.
DOI: 10.1093/brain/awad375.
Morvan M, Teque F, Locher C, Levy J
Microbiol Mol Biol Rev. 2021; 85(2).
PMID: 33980586
PMC: 8139528.
DOI: 10.1128/MMBR.00155-20.
Arantes I, Ribeiro-Alves M, de Azevedo S, Delatorre E, Bello G
PLoS One. 2020; 15(9):e0238995.
PMID: 32960906
PMC: 7508567.
DOI: 10.1371/journal.pone.0238995.
Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region.
Gomes S, da Silva Graca Amoras E, Gomes E, Queiroz M, Junior E, Mota de Vasconcelos Massafra J
BMC Infect Dis. 2020; 20(1):546.
PMID: 32711474
PMC: 7382849.
DOI: 10.1186/s12879-020-05268-0.
Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death.
Paim A, Badley A, Cummins N
AIDS Res Hum Retroviruses. 2019; 36(2):101-115.
PMID: 31659912
PMC: 7044792.
DOI: 10.1089/AID.2019.0213.
Vpr and Its Cellular Interaction Partners: R We There Yet?.
Fabryova H, Strebel K
Cells. 2019; 8(11).
PMID: 31652959
PMC: 6912716.
DOI: 10.3390/cells8111310.
An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers.
Ding J, Ma L, Zhao J, Xie Y, Zhou J, Li X
J Transl Med. 2019; 17(1):35.
PMID: 30665429
PMC: 6341564.
DOI: 10.1186/s12967-019-1777-7.
R77Q and Q3R HIV1-VPR mutations in an otherwise asymptomatic 5-year-old child with repeated ear infections.
Soares R, Rocha G, Nogueira C, Melico-Silvestre A, Goncalves T
JMM Case Rep. 2017; 1(4):e002709.
PMID: 28663807
PMC: 5415930.
DOI: 10.1099/jmmcr.0.002709.
Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.
Gonzalo-Gil E, Ikediobi U, Sutton R
Yale J Biol Med. 2017; 90(2):245-259.
PMID: 28656011
PMC: 5482301.
Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences.
C Antell G, Dampier W, Aiamkitsumrit B, Nonnemacher M, Pirrone V, Zhong W
Int J Genomics. 2017; 2017:4081585.
PMID: 28620613
PMC: 5460428.
DOI: 10.1155/2017/4081585.
Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.
Weber J, Gibson R, Sacka L, Strunin D, Hodek J, Weberova J
AIDS Res Ther. 2017; 14:15.
PMID: 28331526
PMC: 5359922.
DOI: 10.1186/s12981-017-0144-0.
The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.
Gonzalez M
Int J Mol Sci. 2017; 18(1).
PMID: 28075409
PMC: 5297760.
DOI: 10.3390/ijms18010126.
Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.
Rossenkhan R, MacLeod I, Brumme Z, Magaret C, Sebunya T, Musonda R
AIDS Res Hum Retroviruses. 2016; 32(10-11):1031-1045.
PMID: 27349335
PMC: 5067802.
DOI: 10.1089/AID.2015.0330.
The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo.
Kubler J, Kirschner S, Hartmann L, Welzel G, Engelhardt M, Herskind C
Oncotarget. 2016; 7(29):45500-45512.
PMID: 27275537
PMC: 5216737.
DOI: 10.18632/oncotarget.9787.
Defining the roles for Vpr in HIV-1-associated neuropathogenesis.
James T, Nonnemacher M, Wigdahl B, Krebs F
J Neurovirol. 2016; 22(4):403-15.
PMID: 27056720
PMC: 5144576.
DOI: 10.1007/s13365-016-0436-5.
Bacterial DNA Protects Monocytic Cells against HIV-Vpr-Induced Mitochondrial Membrane Depolarization.
Saxena M, Busca A, Holcik M, Kumar A
J Immunol. 2016; 196(9):3754-67.
PMID: 26969755
PMC: 5488333.
DOI: 10.4049/jimmunol.1402379.
Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users.
Lin P, Lai C, Yang J, Huang H, Huang M, Tsai M
Emerg Microbes Infect. 2015; 2(12):e83.
PMID: 26038447
PMC: 3880871.
DOI: 10.1038/emi.2013.83.
Visualizing Vpr-induced G2 arrest and apoptosis.
Murakami T, Aida Y
PLoS One. 2014; 9(1):e86840.
PMID: 24466265
PMC: 3899331.
DOI: 10.1371/journal.pone.0086840.